Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris
Summary
Inventiva halted trading of its ordinary shares on Euronext Paris ahead of a planned financing transaction. The company said it will issue more details in a separate announcement. Trading on Euronext Paris is expected to resume later the same day, with Nasdaq ADS trading also expected to begin. Inventiva remains focused on developing lanifibranor for MASH in its ongoing Phase 3 program.
Funding
Amount
None
Total raised
Date
June 2, 2026
Announcement date
Investors
-
Lead investors
Company
inventivapharma.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected